Ascendis Pharma A/S - ADR (ASND) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

ASND ratio: 34%

100%

ASND beat 12 of 35 last estimates

Date of next report: Feb 5, 2025

Estimate for Q4 24: $-1.40

Implied change from Q3 24: -25.93%

Implied change from Q4 23: -15.66%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 14, 2024	$-1.89 / $-1.49	$-0.4 / -26.85%
Q2 24	Sep 3, 2024	$-2.05 / $-1.54	$-0.51 / -33.12%
Q1 24	May 2, 2024	$-2.48 / $-1.57	$-0.91 / -57.96%
Q4 23	Feb 7, 2024	$-1.66 / $-2.15	$0.49 / 22.79%
Q3 23	Nov 7, 2023	$-3.12 / $-2.63	$-0.49 / -18.63%
Q2 23	Sep 5, 2023	$-2.35 / $-2.68	$0.33 / 12.31%
Q1 23	Apr 27, 2023	$-2.12 / $-2.84	$0.72 / 25.35%
Q4 22	Feb 16, 2023	$-3.78 / $-2.5	$-1.28 / -51.2%

Data Vendor: Xignite Logo